Author:
Rodrigues Clenilson Martins,Bento Charlyana Carvalho,Moraes Carolina Borsoi,Gomes Cecilia,Ioshino Rafaella Sayuri,Freitas-Junior Lucio H.,de Castro Spadari Cristina,Ishida Kelly,Vilegas Wagner,Carvalho Juliana Cajado Souza,Ferreira Marcelo José Pena,Carbone Virginia,Piacente Sonia,Molina de Angelo Rafaela,Honorio Kathia Maria,Sannomiya Miriam
Subject
Drug Discovery,Pharmacology,General Medicine
Reference40 articles.
1. Coronavirus (2019-nCoV): Situation Report, 19;World Health Organization,2023
2. Effectiveness of COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe outcomes with variants of concern in Ontario;Nasreen;Nat. Microbiol.,2022
3. Confronting the delta variant of SARS-CoV-2, summer;del Rio;JAMA.,2021
4. Research and development on therapeutic agents and vaccines for COVID-19 and related human coronavirus diseases;Liu;ACS Cent. Sci.,2022
5. Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-blind, randomised, placebo-controlled, phase 3 trial;Kalil;Lancet Respir. Med.,2021